Global Cervical Cancer Diagnostic Testing Market to 2023 - Market will Register a CAGR of More than 6%

DUBLIN, Nov 21, 2018 /PRNewswire/ --

The "Global Cervical Cancer Diagnostic Testing Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

The cervical cancer diagnostic testing market will register a CAGR of more than 6% by 2023

With the growth in geriatric population worldwide, the increasing age plays a significant prognostic role in the development of cervical cancer. According to the US Census Bureau, the global geriatric population (65 years and above) is expected to exceed 1.5 billion by 2050, making it approximately 16% of the total world's population.

Market Overview

Increased adoption of HPV home testing kits

Several large companies are focused on R&D of new and innovative products that can provide accurate and instant test results at home and cut down cost burden on the patients on management of cervical cancer. In addition, the rising awareness on the importance of cervical cancer screen on time will fuel the demand for cervical cancer diagnostic market during the next five years.

Varying screening policies

The recommended screening policies for cervical cancer usually vary in different countries. Although certain professional societies and organizations have developed guidelines, efforts are needed for their uniform implementation. The difference in the target age can lead to shortcomings in terms of routine registration for the screening program, evaluation, and monitoring, which can negatively impact the adoption of cervical cancer diagnostic testing.

Competitive Landscape

The market appears to be quite fragmented but will become highly concentrated with the presence of a few companies including Abbott Laboratories and BD, the competitive environment is very intense. Factors such as the growth in geriatric population and increased adoption of HPV home testing kits, will provide considerable growth opportunities to cervical cancer diagnostic testing vendors. Abbott Laboratories, BD, F. Hoffmann-La Roche, Hologic, and QIAGEN are some of the major companies covered in this report.

Report Summary:

One trend affecting this market is the growth in geriatric women population. The increasing age plays a significant prognostic role in the development of cervical cancer. Globally, the population or elderly women is increasing.

According to the report, one driver influencing this market is the increased adoption of HPV home testing kits. Leading vendors have developed innovative home-based products that provide quick and accurate test results which helps in reducing costs for patients and management of cervical cancer.

Further, the report states that one challenge affecting this market is the varying screening policies. The recommended screening policies for cervical cancer usually vary in different countries. Although certain professional societies and organizations have developed guidelines, efforts are needed for their uniform implementation, which poses a challenge for the growth of the market.

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 04: MARKET SIZING

• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 06: MARKET SEGMENTATION BY END-USER

PART 07: MARKET SEGMENTATION BY TYPE

• Market segmentation by type
• Comparison by type
• Pap smear test - Market size and forecast 2018-2023
• HPV testing - Market size and forecast 2018-2023
• Market opportunity by type

PART 08: CUSTOMER LANDSCAPE

PART 09: MARKET SEGMENTATION BY TECHNOLOGY

PART 10: GEOGRAPHIC LANDSCAPE

• Geographic segmentation
• Geographic comparison
• Americas - Market size and forecast 2018-2023
• EMEA - Market size and forecast 2018-2023
• APAC - Market size and forecast 2018-2023
• Key leading countries
• Market opportunity

PART 11: MARKET SEGMENTATION BY METHOD

PART 12: DECISION FRAMEWORK

PART 13: DRIVERS AND CHALLENGES

• Market drivers
• Market challenges

PART 14: MARKET TRENDS

PART 15: VENDOR LANDSCAPE

• Overview
• Landscape disruption

PART 16: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Abbott Laboratories
• BD
• F. Hoffmann-La Roche
• Hologic
• QIAGEN

PART 17: APPENDIX

For more information about this report visit https://www.researchandmarkets.com/research/3wkp4d/global_cervical?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets